Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:503379rdf:typepubmed:Citationlld:pubmed
pubmed-article:503379lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:503379lifeskim:mentionsumls-concept:C0030790lld:lifeskim
pubmed-article:503379lifeskim:mentionsumls-concept:C0017436lld:lifeskim
pubmed-article:503379lifeskim:mentionsumls-concept:C0027780lld:lifeskim
pubmed-article:503379lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:503379pubmed:issue5lld:pubmed
pubmed-article:503379pubmed:dateCreated1980-1-28lld:pubmed
pubmed-article:503379pubmed:abstractTextSeventy-five women admitted with the symptom complex suggestive of pelvic inflammatory disease( PID) were started on a penicillin-aminoglycoside antibiotic regimen. An aminoglycoside, gentamicin or netilmicin (Schering-Plough), was chosen randomly and given parenterally. Forty-two patients received netilmicin and 33 received gentamicin for 5 days. Therapeutic response to the 2 antibiotic regimens was similar. Aminoglycosides have been associated with both nephrotoxicity and ototoxicity. Blood chemistries were studied in all patients. The only manifested toxicity was in 2 patients treated with gentamicin. Endometrial-endocervical cultures were obtained before and after therapy. The microbacteria isolated by standard culture techniques before therapy revealed Neisseria gonorrhoeae in 69% and 51% of the netilmicin and gentamicin groups, respectively; anaerobic organisms were cultured in about 75% of each group.lld:pubmed
pubmed-article:503379pubmed:languageenglld:pubmed
pubmed-article:503379pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:503379pubmed:citationSubsetAIMlld:pubmed
pubmed-article:503379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:503379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:503379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:503379pubmed:statusMEDLINElld:pubmed
pubmed-article:503379pubmed:monthNovlld:pubmed
pubmed-article:503379pubmed:issn0029-7844lld:pubmed
pubmed-article:503379pubmed:authorpubmed-author:PoindexterA...lld:pubmed
pubmed-article:503379pubmed:authorpubmed-author:SchniderGGlld:pubmed
pubmed-article:503379pubmed:authorpubmed-author:BirkenR ARAlld:pubmed
pubmed-article:503379pubmed:issnTypePrintlld:pubmed
pubmed-article:503379pubmed:volume54lld:pubmed
pubmed-article:503379pubmed:ownerNLMlld:pubmed
pubmed-article:503379pubmed:authorsCompleteYlld:pubmed
pubmed-article:503379pubmed:pagination554-7lld:pubmed
pubmed-article:503379pubmed:dateRevised2009-10-26lld:pubmed
pubmed-article:503379pubmed:meshHeadingpubmed-meshheading:503379-H...lld:pubmed
pubmed-article:503379pubmed:meshHeadingpubmed-meshheading:503379-P...lld:pubmed
pubmed-article:503379pubmed:meshHeadingpubmed-meshheading:503379-F...lld:pubmed
pubmed-article:503379pubmed:meshHeadingpubmed-meshheading:503379-A...lld:pubmed
pubmed-article:503379pubmed:meshHeadingpubmed-meshheading:503379-A...lld:pubmed
pubmed-article:503379pubmed:meshHeadingpubmed-meshheading:503379-P...lld:pubmed
pubmed-article:503379pubmed:meshHeadingpubmed-meshheading:503379-D...lld:pubmed
pubmed-article:503379pubmed:meshHeadingpubmed-meshheading:503379-G...lld:pubmed
pubmed-article:503379pubmed:meshHeadingpubmed-meshheading:503379-N...lld:pubmed
pubmed-article:503379pubmed:year1979lld:pubmed
pubmed-article:503379pubmed:articleTitleA comparison of netilmicin and gentamicin in the treatment of pelvic infections.lld:pubmed
pubmed-article:503379pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:503379pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:503379pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:503379pubmed:publicationTypeRandomized Controlled Triallld:pubmed